Main Page

Main Page


Corporate Mission

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.

Our Lead Product

Our lead product is an anti-cancer DNA vaccine, Elenagen™, which is effective against a broad spectrum of primary tumors and metastatic processes. We believe, Elenagen™ is the only anti-cancer biological, which combines two mechanisms of action, stimulating anti-cancer immunity and mitigating chronic inflammation.

Clinical Trials

The CureLab Oncology team has completed its international Phase I/IIa Clinical Trials of our anti-cancer vaccine Elenagen™ .The vaccine demonstrated high degree of safety as well as clinical benefits in a number of patients. Based off the success of these results, we plan to initiate Phase II Clinical Trials in US and other countries.
Разработка SEO-Online
Работает на Amiro.CMS - Free